Husni Samara | Quantitative Hypotheses | Best Researcher Award

Posted on by ScienceFather

Husni Samara | Quantitative Hypotheses | Best Researcher Award

Dr Husni Samara, University of Valencia, Spain

Dr. Husni Samara 🎓📊 is a Ph.D. student in Accounting at the University of Valencia, Spain, specializing in corporate governance and sustainability 🌍. He holds a Master’s (2018-2020) and a Bachelor’s (2009-2013) in Financial Accounting, both with excellent standings 🏆. With extensive academic experience as a part-time instructor at various universities 📚, he also worked as a financial and administrative accountant in the UAE and Palestine 💼. His research spans corporate governance, fintech, AI in accounting, and sustainability, with multiple publications in reputable journals 📑. His upcoming studies focus on green banking, ESG, and financial performance insights 🌱💰.

Publication Profile

Google Scholar

Orcid

Scopus

Education

Dr. Husni Samara is a Ph.D. student in the Department of Accounting at the University of Valencia, Spain (2024–Present) 📚🌍. His research focuses on corporate governance and sustainability 🌱🏢. He earned his Master’s degree in Financial Accounting from the University of Jordan (2018–2020) with an excellent standing (3.97/4) 🎓✨, where his thesis explored the impact of corporate governance and firm characteristics on firm value in Jordan 📊🏦. He previously obtained his Bachelor’s degree in Financial Accounting from the Arab American University, Palestine (2009–2013) with a stellar GPA of 3.92/4 🏅📖, demonstrating his strong academic foundation in finance.

Experience

Dr. Husni Samara is a dedicated educator in accounting and financial sciences 📊📚. He serves as a part-time instructor at Al Zaytona University of Science and Technology in Salfit, Palestine (2023-2024), teaching in the Faculty of Business Management and the Technical Community College’s Insurance Office Services Diploma program 🏢💼. Previously, he was a part-time instructor at Al-Quds Open University in Jenin and Nablus (2021-2022), contributing to the Faculty of Administrative and Financial Sciences 🏫📖. His expertise and commitment to education help shape future professionals in accounting and business administration 💡🎓.

Research Interest

Dr. Husni Samara is a dedicated researcher specializing in sustainability 🌱, quantitative research in accounting 📊, and corporate governance 🏛️. His expertise spans various accounting issues 💼, where he applies data-driven approaches to enhance financial decision-making and transparency. With a keen focus on corporate responsibility and sustainable business practices, Dr. Samara contributes valuable insights to the evolving field of accounting. His research supports organizations in improving governance structures and financial reporting accuracy. Through his work, he bridges the gap between quantitative analysis and practical applications, fostering ethical and sustainable financial practices in the corporate world. 📈✅

Research Focus

Dr. Husni Samara’s research focuses on corporate governance 🏛️, financial technologies 💳📲, and business performance 📈 in emerging markets. His work examines the impact of digital finance on entrepreneurship 🚀, board structures in firm valuation 💼, and the role of conservative accounting in financial adequacy 💰. He also explores intangible assets and ESG integration 🌱, artificial intelligence in governance 🤖, and financial technology’s role in social responsibility 🌍. His contributions provide valuable insights into banking performance 🏦, energy economics ⚡, and digital education 📚, making a significant impact on finance, corporate strategy, and business sustainability.

Publication Top Notes

The impact of digital financial technologies on the development of entrepreneurship: Evidence from commercial banks in the emerging markets

The effect of corporate governance and firm characteristics on firm value: evidence from Jordan

Does board structure matter firm’s value? The Jordanian evidence

The linkage between conservative accounting and financial adequacy and the moderating role of corporate governance

Modeling and mediating the interaction between oil prices and economic sectors advancement: The case of Middle East

Financial technology’s role in advancing social responsibility: a bibliometric review of research progress and future opportunities

The role of human resource re-engineering in order to improve the quality of banking performance

Digital technologies in business education: a hybrid literature review from the Web of Science database

Artificial intelligence and machine learning in corporate governance: A bibliometric analysis

Mahadih Kyambade | Qualitative Hypotheses | Best Scholar Award

Posted on by ScienceFather

Mahadih Kyambade | Qualitative Hypotheses | Best Scholar Award

Mr Mahadih Kyambade, Makerere University Business School, Uganda

Mahadih Kyambade is an Assistant Lecturer at Makerere University Business School (MUBS) in the Department of Leadership and Governance. Holding a Master’s in Leadership and Governance, he is an accomplished academic and researcher with expertise in leadership, governance, and management. Recognized as the Best Early Career Researcher at MUBS, Kyambade’s work has been published in top journals like Emerald, Taylor & Francis, and Springer. He actively contributes as a peer reviewer for journals in leadership, education, and healthcare management. His research addresses critical issues like climate change, resilience, and ethical leadership. 📚🌍💼

Publication Profile

Orcid

Academic Qualification 

Mahadih Kyambade holds a Bachelor’s degree in Leadership and Governance, followed by a Master of Science in Leadership and Governance. His academic journey reflects a deep commitment to understanding and shaping effective leadership frameworks within organizational and societal contexts. With expertise in governance structures, policy implementation, and strategic leadership, Mahadih is equipped with the knowledge to drive positive change and make impactful decisions. His studies have focused on the intersection of leadership, governance, and sustainable development. 🌟📚🌍💼

Recognition as an Early Career Researcher

Mr. Mahadih Kyambade has earned recognition as the Best Early Career Researcher at Makerere University Business School (MUBS) 🌟, highlighting the significant contributions he has made to his academic field. His dedication to research and his ability to inspire those around him have established him as a promising scholar 🌱📚. Through his innovative work, he has not only elevated his personal academic journey but also positively influenced the MUBS community 🏫. This award underscores his potential for future achievements in research, and it reflects his commitment to academic excellence and growth 👏🎓.

Editorial Contributions

Mr. Mahadih Kyambade is a respected peer reviewer for prominent journals, including the International Journal of Educational Management, Cogent Education, and Journal of Nursing Management. 🌍📚 His expertise is recognized globally, reflecting his significant contributions to the academic community. Through his active participation, he plays a key role in shaping research and advancing knowledge. ✍️🔍 Mr. Kyambade’s commitment to excellence and his influence in the field demonstrate his dedication to fostering scholarly growth and improving academic standards. 💡🌱 His continued engagement in the research community highlights his passion for education and knowledge development.

Impactful Research Topics

Mr. Mahadih Kyambade’s work focuses on critical global issues such as climate change, environmental disasters, resilience, and ethical leadership. His research significantly contributes to the academic field while providing practical insights for governance, leadership, and management practices. His studies are especially impactful in developing regions like Uganda, where effective leadership and resilience strategies are crucial in addressing environmental challenges. Through his work, he emphasizes the importance of ethical leadership and sustainable practices in fostering community resilience and promoting positive change. 🌍🌱💡📚🌿

Publication Top Notes

Insights on climate change in a business university setting: a case of Environmental Management students

Work from home can be distracting: Exploring the moderation role of transformational leadership on teleworking and cyber-slacking

The impact of ethical leadership and code of ethics on employee integrity, mediated by job satisfaction in Uganda’s public sector

Navigating trauma: mental well-being after Kiteezi landfill collapse and residential displacement in Uganda

Socially responsible leadership practices in university context: a developing nation perspective

Collective Leadership, Workplace Democracy and Diversity Management in Public Universities in Uganda

Bridging the gender gap: analyzing women’s participation and leadership representation in university governance

I can’t express myself at work: encouraging socially responsible leadership and psychological safety in higher education setting

Servant leadership and healthy work relationships in university context: a moderated mediation analysis of psychological safety and socially responsible leadership

Jaffer Ajani | Gastric Cancer | Best Researcher Award

Posted on by ScienceFather

Jaffer Ajani | Gastric Cancer | Best Researcher Award

Dr Jaffer Ajani, MD Anderson Cancer CENTER, United States

Dr. Jaffer Ajani, a distinguished oncologist and researcher at UT MD Anderson Cancer Center, specializes in esophageal and gastric cancers. With over 30 years of clinical and translational research experience, he has led groundbreaking trials that established new standards of care, including approvals for drugs like docetaxel, S1, and ramucirumab. Dr. Ajani’s laboratory focuses on tumor-immune interactions and cellular heterogeneity, employing cutting-edge single-cell sequencing technologies. He has authored numerous high-impact publications and oversees a robust research infrastructure. Recognized as a Giant of Cancer Care in 2022, his dedication advances treatment options and improves patient outcomes. 🧬📚💊👨‍⚕️

Publication Profile

google scholar

Education

Dr. Jaffer Ajani is a distinguished medical professional who earned his M.D. degree in Medicine from Government Medical College, Nagpur, India, in June 1971. With a strong foundation in medicine, Dr. Ajani has dedicated his career to advancing healthcare and contributing to medical research. His extensive expertise and commitment to excellence have made him a respected figure in the medical community. 🌟📚🩺 Dr. Ajani’s journey in medicine reflects his passion for improving patient outcomes and his dedication to lifelong learning, serving as an inspiration to aspiring healthcare professionals worldwide. 🌍👨‍⚕️✨

Pioneering Clinical Research

Dr. Ajani has led multiple clinical trials, including three pivotal Phase III studies that resulted in FDA approval for new drugs like docetaxel, S1, and ramucirumab. His work has directly improved the standard of care for gastric and esophageal cancer patients 🌟. By advancing treatment options, he has made significant contributions to cancer therapy and patient outcomes 💊. His research continues to drive progress in oncology, aiming to enhance quality of life and survival rates for patients facing these challenging conditions 🚀.

Translational Research Leadership

With over 20 years of experience in translational research, Dr. Jaffer Ajani has established an outstanding infrastructure at UT MD Anderson Cancer Center, housing tissue and clinical data from over 4,000 patients. His lab’s discoveries, including the roles of Yap1, SOX9, and LIF in immune suppression, have significantly advanced our understanding of tumor biology. 🌟🔬📊

Innovative Use of Technology

Dr. Jaffer Ajani utilizes cutting-edge single-cell sequencing technologies and computational modeling to analyze tumor-immune interactions and tumor heterogeneity. His research provides significant insights into tumor origin and immune evasion, advancing our understanding of cancer biology. By examining the complexities of tumor environments, Dr. Ajani’s work aims to develop targeted therapies that can more effectively combat cancer. His studies contribute to the field’s broader goals of improving treatment outcomes and personalizing cancer care. 🧬🔬🏥

Distinguished Contributions

Dr. Jaffer Ajani is a respected researcher with extensive contributions to oncology. He has co-authored highly cited publications in leading journals such as Nature Medicine, The New England Journal of Medicine, and The Lancet, including groundbreaking studies that have reshaped treatment paradigms. Notable among his work are studies on Nivolumab combinations for esophageal and gastric cancers. His research continues to impact the field significantly, advancing our understanding of cancer treatment and improving patient outcomes. 🌟📚🧬

Recognitions and Impact

Dr. Jaffer Ajani’s accolades reflect his outstanding contributions to cancer care. Inducted into the GIANTS of CANCER CARE in 2022 and a Fellow of ASCO since 2017, his expertise has been widely recognized. His consistent presence in the Best Doctors in America list since 1991 underscores his enduring clinical excellence. 🌟🏆🔬

Research Focus

Dr. Jaffer Ajani’s research primarily focuses on cancer treatment and the molecular characterization of gastric adenocarcinoma. His work, particularly in the AJCC cancer staging and the comprehensive characterization of cancer driver genes, has significantly contributed to understanding and managing this disease. His studies, such as those published in Nature and Cell, explore the immune landscape of cancer and oncogenic signaling pathways, aiming to improve therapeutic outcomes. His research also involves clinical trials like the CheckMate 649, assessing novel treatment strategies like nivolumab combined with chemotherapy, highlighting his emphasis on integrating molecular data with clinical practice for better cancer management. 🌐🔬🧬

Publication Top Notes

AJCC cancer staging manual

Comprehensive molecular characterization of gastric adenocarcinoma

The immune landscape of cancer

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics

Oncogenic signaling pathways in the cancer genome atlas

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 …

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a …

Comprehensive characterization of cancer driver genes and mutations

Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer

Anna Nikitjuka | Chemistry and Materials Science | Best Researcher Award

Posted on by ScienceFather

Anna Nikitjuka | Chemistry and Materials Science | Best Researcher Award

Dr Anna Nikitjuka, Latvian Institute of Organic Synthesis, Latvia

Dr. Anna Nikitjuka, she appears to be a strong candidate for the Research for Best Researcher Award. Here’s an analysis of her qualifications, work experience, projects, and publications, concluding with a summary of her suitability for the award.

Publication profile

Orcid

Education

Dr. Nikitjuka holds a Doctorate in Chemical Science from the University of Latvia, where she worked under the supervision of Prof. Dr. Aigars Jirgensons. She also earned a Master of Natural Sciences in Chemistry from the same institution, further demonstrating her extensive background in chemistry.

Work Experience

Dr. Nikitjuka has an impressive track record of research experience, including her current position as a Principal Researcher at the Latvian Institute of Organic Synthesis. Her previous roles include a Researcher and Research Assistant at the same institute, showcasing a continuous commitment to advancing chemical research. She has also engaged in multiple postdoctoral projects across prominent European universities, enhancing her international exposure and collaboration experience.

Reviewer and Editorial Experience

Dr. Nikitjuka has served as a reviewer for esteemed journals such as Medicinal Chemistry Research and has taken on editorial roles, including co-guest editor for a special issue on Anti-Cancer Agents in Medicinal Chemistry. This involvement highlights her active engagement in the scientific community and her commitment to advancing research in medicinal chemistry.

Projects

Dr. Nikitjuka has led several significant research projects, such as the PostDoc grant and ISIDORA project, reflecting her leadership capabilities and expertise in the field. Her involvement in these projects indicates her ability to drive research initiatives successfully.

Publication top notes

Spiropyran‐Based Photoisomerizable α‐Amino Acid for Membrane‐Active Peptide Modification

Design, Synthesis, and Bioactivity Evaluations of 3‐Methylenechroman‐2‐one Derivatives as Thioredoxin Reductase (TrxR) Inhibitors

Exploration of 3,4-unsubstituted coumarins as thioredoxin reductase 1 inhibitors for cancer therapy

Given Dr. Anna Nikitjuka’s robust educational background, extensive research experience, active involvement in the scientific community through editorial roles, and her impactful publications, she is indeed a suitable candidate for the Research for Best Researcher Award. Her commitment to advancing knowledge in chemistry and her leadership in significant projects demonstrate her potential to make substantial contributions to the field.

 

 

Mediatrice NIYONSABA | Qualitative Hypotheses | Best Paper Award

Posted on by ScienceFather

Mediatrice NIYONSABA | Qualitative Hypotheses | Best Paper Award

Mrs Mediatrice NIYONSABA, Rwanda Biomedical center, Rwanda

Mediatrice Niyonsaba is a dedicated health professional and researcher. Currently a second-year Master’s student in Epidemiology at the University of Rwanda, she holds a Bachelor’s degree in Anesthesia from the same institution. Since 2012, she has served as an anesthesia clinical officer at RBC/SAMU 🚑. Her research includes co-authoring a study on motorcycle crash epidemiology in Kigali and assisting in several projects, including those on anemia in trauma, substance abuse screening, and the impact of COVID-19 on CNS injuries. She is the lead author of a study on mHealth tools in prehospital care, published in the African Journal of Emergency Medicine 📚.

Publication profile

scupos

Education

Since November 2021, she have been pursuing a Master of Science in Epidemiology at the University of Rwanda’s College of Medicine and Health Sciences 📚. I previously earned a Bachelor’s degree in Anesthesia from the same university (2015-2017) 🎓. My professional journey includes working as an anesthesia clinical officer at RBC/SAMU (Service d’Aide Medicale d’Urgence) since November 2012 🏥. Before that, I taught Biology at SAKE Secondary School from January to November 2009 👩‍🏫.

Experience

Since January 2019, I’ve been part of the SAMU team collaborating with Utah University to develop and pilot test a mobile health communication tool (912 m Health tool) aimed at enhancing emergency medical services 🚑. I co-authored “Epidemiology and prehospital care of motorcycle crashes in Kigali, Rwanda,” published in November 2019 🏍️. From January to April 2020, I was a research assistant for the Kigali Anemia in Trauma and Transfusion Study at CHUK 🏥. Between August 2020 and September 2021, I assisted in adapting screening instruments for detecting alcohol and drug abuse in Rwanda using ACASI 🍷💊. In late 2021, I contributed to research on the impact of COVID-19 on CNS injury treatment and outcomes 🧠. Recently, I authored “Challenges and opportunities to improve efficiency and quality of prehospital emergency care using an m Health platform,” published in the African Journal of Emergency Medicine in September 2023 📚.

Research focus

Dr. Sharmistha Jayaraman’s research focuses primarily on improving prehospital emergency care and trauma management in low-resource settings, particularly in Rwanda. Her studies encompass various aspects of emergency medical services (EMS), including challenges in locating emergency scenes 🚑, enhancing efficiency through m Health platforms 📱, neurotrauma management 🧠, and the epidemiology of trauma, such as motorcycle crashes 🏍️. Additionally, Dr. Jayaraman investigates the initial management of traumatic brain injuries and factors influencing HIV testing among emergency patients. Her work aims to improve healthcare outcomes by addressing critical gaps in prehospital care and emergency response systems in Sub-Saharan Africa.

Publication top notes

Challenges Locating the Scene of Emergency: A Qualitative Study of the EMS System in Rwanda

Challenges and opportunities to improve efficiency and quality of prehospital emergency care using an mHealth platform: Qualitative study in Rwanda

Trends in Neurotrauma Epidemiology, Management, and Outcomes during the COVID-19 Pandemic in Kigali, Rwanda

Factors associated with HIV testing among patients seeking emergent injury care in Kigali, Rwanda

The Initial Prehospital Management of Traumatic Brain Injuries in Kigali, Rwanda

The epidemiology and prehospital care of motorcycle crashes in a sub-Saharan African urban center

Data-driven prehospital training to decrease motorcycle crash deaths in a Sub-Saharan African urban center

 

Outstanding Hypothesis Investigation Award

Posted on by ScienceFather

Outstanding Hypothesis Investigation Award

Introduction:

Step into the realm of groundbreaking inquiry and discovery with the Outstanding Hypothesis Investigation Award. This prestigious accolade celebrates the exceptional individuals who delve deep into hypotheses, uncovering new insights and pushing the boundaries of knowledge.

About the Award:

The Outstanding Hypothesis Investigation Award recognizes individuals who demonstrate exemplary dedication and skill in investigating hypotheses, leading to significant advancements in their respective fields of study.

Eligibility:

  • Age Limits: None; open to individuals of all ages.
  • Qualification: Candidates must have a proven track record of conducting thorough investigations into hypotheses that have resulted in notable contributions to their field.
  • Publications: Nominees should have a record of publishing their investigative findings in reputable academic journals or presenting them at conferences.
  • Requirements: Nominees must meet specific criteria outlined by the award committee.

Evaluation Criteria:

Candidates are evaluated based on the depth, rigor, and impact of their investigative work. The clarity of hypothesis investigation, the strength of supporting evidence, and the significance of the findings are key considerations.

Submission Guidelines:

Nomination packages should include a comprehensive biography highlighting the nominee's academic and research achievements, an abstract outlining the hypothesis investigation and its implications, and supporting files such as publications, presentations, or research data. Submissions must adhere to the specified format and guidelines provided by the award committee.

Recognition:

Recipients of the Outstanding Hypothesis Investigation Award receive prestigious recognition for their contributions to advancing knowledge through rigorous investigative work, including media coverage, networking opportunities, and a formal presentation of the award.

Community Impact:

Winners of the award inspire and catalyze further research and inquiry within their respective fields, fostering collaboration, innovation, and the pursuit of new discoveries.

Research Hypothesis Excellence Award

Posted on by ScienceFather

Research Hypothesis Excellence Award

Introduction:

Step into the realm of research innovation and discovery with the Research Hypothesis Excellence Award. This prestigious honor celebrates the outstanding minds behind groundbreaking hypotheses that drive scientific inquiry and shape the future of knowledge.

About the Award:

The Research Hypothesis Excellence Award recognizes individuals who have demonstrated exceptional skill and insight in formulating hypotheses that advance our understanding of the world. It celebrates the critical role of hypotheses in driving forward the frontiers of research and discovery.

Eligibility:

  • Age Limits: None; open to individuals of all ages.
  • Qualification: Candidates must have a proven track record of formulating hypotheses that have made significant contributions to their field of study.
  • Publications: Nominees should have a record of publishing their hypotheses and research findings in reputable academic journals.
  • Requirements: Nominees must meet specific criteria outlined by the award committee.

Evaluation Criteria:

Candidates are evaluated based on the originality, significance, and impact of their hypotheses. The clarity of hypothesis formulation, strength of supporting evidence, and potential for advancing knowledge are key considerations.

Submission Guidelines:

Nomination packages should include a comprehensive biography highlighting the nominee's academic and research achievements, an abstract outlining the research hypothesis and its implications, and supporting files such as publications, presentations, or research data. Submissions must adhere to the specified format and guidelines provided by the award committee.

Recognition:

Recipients of the Research Hypothesis Excellence Award receive prestigious recognition for their contributions to advancing scientific knowledge, including media coverage, networking opportunities, and a formal presentation of the award.

Community Impact:

Winners of the award inspire and catalyze further research and innovation within their respective fields, fostering collaboration, dialogue, and the pursuit of new discoveries.